| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Silencing of hsa_circ_0007534 suppresses CRC cell proliferation and induces apoptosis; hsa_circ_0007534 is implicated in CRC initiation and progression. |
| Molecular mechanism: |
Silencing hsa_circ_0007534 induces apoptosis with increased caspase-3 activity and decreased Bcl-2/Bax ratio in CRC cells. |
| Biological pathway or process: |
proliferation (promotes); apoptosis (inhibits) |
| Detected method: |
Q
M
|
| Validation methods: |
RNase R Treatment; Microarray; Back-Splice Junction PCR / divergent primers PCR; RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Annexin V/PI Flow Cytometry; Western Blot |
| Clinical significance: |
hsa_circ_0007534 expression was correlated with tumor stage and lymph node metastasis and may be a biomarker or therapeutic target of CRC. |
| Description: |
hsa_circ_0007534 is up-regulated in colorectal cancer tissues and CRC cell lines. Its knockdown suppresses proliferation and induces apoptosis in SW620 and LoVo cells, accompanied by increased caspase-3 activity and reduced Bcl-2/Bax ratio. Clinically, higher hsa_circ_0007534 expression is associated with advanced tumor stage and lymph node metastasis, suggesting potential biomarker and therapeutic relevance. |
| Confidence score: |
0.7046 |